Trial Profile
Double-blinded, Randomized, Active Control Comparative, Parallel-designed, Phase III Clinical Trial: Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." In Essential Blepharospasm Running Parallel With Phase I Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2015
Price :
$35
*
At a glance
- Drugs Letibotulinumtoxina (Primary)
- Indications Blepharospasm
- Focus Registrational; Therapeutic Use
- Sponsors Hugel
- 06 Jun 2015 New trial record